New combo therapy tested for tough stomach cancers
NCT ID NCT07320586
Summary
This study is testing whether combining two drugs, carilizumab and albumin paclitaxel, can help control advanced stomach cancer in patients whose first treatment has stopped working. It will include 40 adults whose cancer progressed after initial chemotherapy, with or without immunotherapy. The main goal is to see how well the combination shrinks tumors and controls the disease, while also monitoring side effects and how long patients live without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong First Medical University Affiliated Cancer Hospital
RECRUITINGJinan, Shandong, 250021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.